European Commission/ EUR-Lex: Council Recommendation on Raising seasonal vaccination coverage among risk groups and healthcare workers (22 December 2009)
Council Recommendation on Raising seasonal vaccination coverage among risk groups and healthcare workers (22 December 2009)
Technical guidance on the Introduction of HPV vaccines in European Union countries – an update
In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.
Technical report In Brief: Narcolepsy in association with pandemic influenza vaccination
This report summarises the results from two epidemiological studies to investigate a possible association between an unexpected increase in narcolepsy cases following the use of the influenza A(H1N1)pdm09 vaccines. The studies were conducted by the Vaccine Adverse Event Surveillance and Communication (VAESCO) Consortium under the auspices of ECDC and undertaken in Denmark, Finland, France, Italy, the Netherlands, Norway, Sweden and the United Kingdom. This Technical Report In Brief accompanies the full Report ‘Narcolepsy in association with pandemic influenza vaccination- A multi-country European epidemiological investigation’.
Measles and rubella monitoring – January 2017
The ECDC measles and rubella monitoring report is published twice a year. The January issue reports on the previous calendar year, while the July issue focuses on the most recent measles and rubella season and presents the data collected over the past 12 months.
Vaccine-preventable diseases and immunisation: Core competencies
This report outlines the development of a competency framework covering key knowledge, skills and attitudes critical for the prevention and control of vaccine-preventable diseases and immunisation.
External quality assessment scheme 2011 for Neisseria meningitidis
This report on EQA performance shows that European Reference Laboratories for Meningococci differ in their capacities and the level of characterisation of the distributed N. meningitidis material, but that there have been improvements since the first ECDC IBD-labnet distribution.